Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled Proof of Concept Study of LY2300559 in Patients With Migraine

NCT01184508 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01184508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01184508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled Proof of Concept Study of LY2300559 in Patients With Migraine
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2011
Completion date
April 30, 2012
Enrollment
87 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache